未知生产厂商
Alefacept is a recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis.
Alefacept is a recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis.
Inhibits T-lymphocyte activation and production by binding to the CD2 lymphocyte antigen.
As an immunosuppressive drug, Alefacept can be used for treatment of moderate to severe chronic plaque psoriasis
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
